a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY

NCT04290611 · clinicaltrials.gov ↗

COMPLETED

Status

500000

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Neuropathy
Epilepsy
Encephalopathy

Interventions

DRUG: Enzalutamide

Sponsor

Groupe Hospitalier Pitie-Salpetriere